M. P. Kachhadia, “Sodium-Glucose Co-Transporter 2 Inhibitor Use and Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis and Type 2 Diabetes: A Retrospective Observational Cohort Study Using Real-World Data”, J Clin Med Res, vol. 18, no. 5, pp. 313–325, Jan. 2026, doi: 10.14740/jocmr6577.